Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Salix Pharmaceuticals Company Profile (NASDAQ:SLXP)

Consensus Ratings for Salix Pharmaceuticals (NASDAQ:SLXP) (?)
Ratings Breakdown: 1 Sell Rating(s), 10 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $131.98 (11.42% upside)

Current Analysts' Coverage Summary for Salix Pharmaceuticals (NASDAQ:SLXP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/18/2014Deutsche BankReiterated RatingHold$107.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Goldman SachsReiterated RatingHOLD$111.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Credit SuisseBoost Price TargetNeutral$111.00 -> $121.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2014Canaccord GenuityBoost Price TargetBuy$117.00 -> $147.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2014Jefferies GroupBoost Price TargetBuy$103.00 -> $123.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2014Piper JaffrayBoost Price Target$130.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2014MizuhoBoost Price TargetNeutral$88.00 -> $103.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2014Sterne AgeeReiterated RatingBuy$130.00 -> $99.01ViewTweet This Rating  Share This Rating on StockTwits
11/6/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Roth CapitalDowngradeBuy -> Neutral$155.00 -> $95.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Stifel NicolausDowngradeBuy -> Hold$185.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014William BlairDowngradeOutperform -> Market Perform$184.00 -> $89.00ViewTweet This Rating  Share This Rating on StockTwits
11/3/2014ZacksDowngradeOutperform -> Neutral$151.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2014Cantor FitzgeraldReiterated RatingBuy$154.00 -> $181.00ViewTweet This Rating  Share This Rating on StockTwits
8/20/2014JMP SecuritiesReiterated RatingMarket Outperform$173.00 -> $190.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Keefe, Bruyette & WoodsReiterated RatingOutperform$160.00 -> $147.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014Leerink SwannReiterated RatingOutperform$162.00 -> $160.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014Brean CapitalBoost Price TargetBuy$125.00 -> $150.00ViewTweet This Rating  Share This Rating on StockTwits
6/10/2014Wells Fargo & Co.Initiated CoverageMarket Perform$126.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2014National Alliance SecuritiesInitiated CoverageBuy$134.62ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014Bank of AmericaDowngradeNeutral -> Underperform$86.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013Janney Montgomery ScottReiterated RatingBuy$95.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013SusquehannaBoost Price Target$75.00 -> $81.00ViewTweet This Rating  Share This Rating on StockTwits
6/12/2013Buckingham ResearchUpgradeNeutral -> Buy$53.00 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
5/28/2013RBC CapitalReiterated RatingBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013WallachBeth CapitalBoost Price TargetHold$45.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/18/2012 forward)